D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,782
- Value
- $2.90M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,782 | $2.90M | <0.1% | −51−0.9% | Reduced | Holders |
| Q1 2026 | 5,833 | $2.87M | <0.1% | +596+11.4% | Added | Holders |
| Q4 2025 | 5,237 | $3.04M | <0.1% | +375+7.7% | Added | Holders |
| Q3 2025 | 4,862 | $2.36M | <0.1% | +192+4.1% | Added | Holders |
| Q2 2025 | 4,670 | $1.89M | <0.1% | −3,960−45.9% | Reduced | Holders |
| Q1 2025 | 8,630 | $4.29M | <0.1% | −110−1.3% | Reduced | Holders |
| Q4 2024 | 8,740 | $4.55M | <0.1% | −1,418−14.0% | Reduced | Holders |
| Q3 2024 | 10,158 | $6.28M | 0.1% | +201+2.0% | Added | Holders |
| Q2 2024 | 9,957 | $5.51M | <0.1% | +395+4.1% | Added | Holders |
| Q1 2024 | 9,562 | $5.56M | 0.1% | +239+2.6% | Added | Holders |
| Q4 2023 | 9,323 | $4.95M | <0.1% | −572−5.8% | Reduced | Holders |
| Q3 2023 | 9,895 | $5.01M | 0.1% | −632−6.0% | Reduced | Holders |
| Q2 2023 | 10,527 | $5.49M | 0.1% | −7−0.1% | Reduced | Holders |
| Q1 2023 | 10,534 | $6.03M | 0.1% | −20.0% | Reduced | Holders |
| Q4 2022 | 10,536 | $5.82M | 0.1% | −30−0.3% | Reduced | Holders |
| Q3 2022 | 10,566 | $5.39M | 0.1% | −100−0.9% | Reduced | Holders |
| Q2 2022 | 10,666 | $5.79M | 0.1% | −177−1.6% | Reduced | Holders |
| Q1 2022 | 10,843 | $6.41M | 0.1% | +14+0.1% | Added | Holders |
| Q4 2021 | 10,829 | $7.22M | 0.1% | +20.0% | Added | Holders |
| Q3 2021 | 10,827 | $6.19M | 0.1% | −164−1.5% | Reduced | Holders |
| Q2 2021 | 10,991 | $5.54M | 0.1% | −336−3.0% | Reduced | Holders |
| Q1 2021 | 11,327 | $5.17M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.